These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30706176)

  • 21. Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma.
    Shinohara C; Muragaki Y; Maruyama T; Shimizu S; Tanaka M; Kubota Y; Oikawa M; Nakamura R; Iseki H; Kubo O; Takakura K; Hori T
    Jpn J Clin Oncol; 2008 Nov; 38(11):730-3. PubMed ID: 18820008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated Na/H exchanger 1 (SLC9A1) emerges as a marker for tumorigenesis and prognosis in gliomas.
    Guan X; Luo L; Begum G; Kohanbash G; Song Q; Rao A; Amankulor N; Sun B; Sun D; Jia W
    J Exp Clin Cancer Res; 2018 Oct; 37(1):255. PubMed ID: 30333031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrence- and Malignant Progression-Associated Biomarkers in Low-Grade Gliomas and Their Roles in Immunotherapy.
    Teng C; Zhu Y; Li Y; Dai L; Pan Z; Wanggou S; Li X
    Front Immunol; 2022; 13():899710. PubMed ID: 35677036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.
    Liang Y; Bollen AW; Aldape KD; Gupta N
    BMC Cancer; 2006 Apr; 6():97. PubMed ID: 16623952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular profiling indicates orthotopic xenograft of glioma cell lines simulate a subclass of human glioblastoma.
    Shankavaram UT; Bredel M; Burgan WE; Carter D; Tofilon P; Camphausen K
    J Cell Mol Med; 2012 Mar; 16(3):545-54. PubMed ID: 21595825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of CD40 Correlates Negatively with Overall and Progression-Free Survival of Low- and High-Grade Gliomas.
    Werner JM; Kuhl S; Ulrich K; Krischek B; Stavrinou P; Goldbrunner R; Timmer M
    World Neurosurg; 2019 Oct; 130():e17-e25. PubMed ID: 31125770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A network model of a cooperative genetic landscape in brain tumors.
    Bredel M; Scholtens DM; Harsh GR; Bredel C; Chandler JP; Renfrow JJ; Yadav AK; Vogel H; Scheck AC; Tibshirani R; Sikic BI
    JAMA; 2009 Jul; 302(3):261-75. PubMed ID: 19602686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel age-associated DNA methylation changes and epigenetic age acceleration in middle-aged African Americans and whites.
    Tajuddin SM; Hernandez DG; Chen BH; Noren Hooten N; Mode NA; Nalls MA; Singleton AB; Ejiogu N; Chitrala KN; Zonderman AB; Evans MK
    Clin Epigenetics; 2019 Aug; 11(1):119. PubMed ID: 31426852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transforming growth factor beta induced (TGFBI) is a potential signature gene for mesenchymal subtype high-grade glioma.
    Pan YB; Zhang CH; Wang SQ; Ai PH; Chen K; Zhu L; Sun ZL; Feng DF
    J Neurooncol; 2018 Apr; 137(2):395-407. PubMed ID: 29294230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
    Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
    BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated expression of chloride intracellular channel 1 is correlated with poor prognosis in human gliomas.
    Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Zhang Y; Gao G
    J Exp Clin Cancer Res; 2012 May; 31(1):44. PubMed ID: 22578365
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tissue Proteome Analysis of Different Grades of Human Gliomas Provides Major Cues for Glioma Pathogenesis.
    Gollapalli K; Ghantasala S; Atak A; Rapole S; Moiyadi A; Epari S; Srivastava S
    OMICS; 2017 May; 21(5):275-284. PubMed ID: 28481733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Race-associated biological differences among Luminal A breast tumors.
    D'Arcy M; Fleming J; Robinson WR; Kirk EL; Perou CM; Troester MA
    Breast Cancer Res Treat; 2015 Jul; 152(2):437-48. PubMed ID: 26109344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Survival and low-grade glioma: the emergence of genetic information.
    Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
    Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma.
    Pangeni RP; Zhang Z; Alvarez AA; Wan X; Sastry N; Lu S; Shi T; Huang T; Lei CX; James CD; Kessler JA; Brennan CW; Nakano I; Lu X; Hu B; Zhang W; Cheng SY
    Epigenetics; 2018; 13(4):432-448. PubMed ID: 29927689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
    Bady P; Kurscheid S; Delorenzi M; Gorlia T; van den Bent MJ; Hoang-Xuan K; Vauléon É; Gijtenbeek A; Enting R; Thiessen B; Chinot O; Dhermain F; Brandes AA; Reijneveld JC; Marosi C; Taphoorn MJB; Wick W; von Deimling A; French P; Stupp R; Baumert BG; Hegi ME
    Acta Neuropathol; 2018 Apr; 135(4):601-615. PubMed ID: 29368212
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glioma risk associated with extent of estimated European genetic ancestry in African Americans and Hispanics.
    Ostrom QT; Egan KM; Nabors LB; Gerke T; Thompson RC; Olson JJ; LaRocca R; Chowdhary S; Eckel-Passow JE; Armstrong G; Wiencke JK; Bernstein JL; Claus EB; Il'yasova D; Johansen C; Lachance DH; Lai RK; Merrell RT; Olson SH; Sadetzki S; Schildkraut JM; Shete S; Houlston RS; Jenkins RB; Wrensch MR; Melin B; Amos CI; Huse JT; Barnholtz-Sloan JS; Bondy ML
    Int J Cancer; 2020 Feb; 146(3):739-748. PubMed ID: 30963577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic reg IV is a novel prognostic marker for glioma patient survival.
    Wang Q; Deng J; Yuan J; Wang L; Zhao Z; He S; Zhang Y; Tu Y
    Diagn Pathol; 2012 Jun; 7():69. PubMed ID: 22713481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A five-microRNA signature for individualized prognosis evaluation and radiotherapy guidance in patients with diffuse lower-grade glioma.
    Zhang JH; Hou R; Pan Y; Gao Y; Yang Y; Tian W; Zhu YB
    J Cell Mol Med; 2020 Jul; 24(13):7504-7514. PubMed ID: 32412186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.